Article

Chronic lymphocytic leukaemia: clinical-aetiological findings in 66 patients and their families.

Clinical Cancer Etiology Unit, Heuberg 16, CH-4051 Basel, Switzerland.
Hereditary Cancer in Clinical Practice (Impact Factor: 1.71). 02/2007; 5(4):210-2. DOI: 10.1186/1897-4287-5-4-210
Source: PubMed

ABSTRACT Little is known about the aetiology of chronic lymphocytic leukaemia (CLL). The family medical history is a "genomic tool" capturing interactions of genetic susceptibility, shared environment and common behaviours.
A cohort of 66 consecutives patients with CLL (probands) was studied in a medical oncology practice (W.W.) from 1981 until 2005. A German version of the NCI medical history questionnaire for cancer aetiology was used. Familial clustering analysis was done by comparing the proportion of specific tumours in the first degree relatives of the CLL practice cohort with corresponding proportions of population-based cancer registry data.
18 (41%) male and 5 (23%) female CLL probands had multiple malignancies, e.g. 2 meningiomas, 7 and 19 years after diagnosis of CLL. 46 (12%) first degree relatives had malignancies with an excess of CLL. Other conspicuous familial associations are CLL with malignancies of the upper GI tract (oesophagus, stomach) and of the nervous system.
1. Chronic lymphocytic leukaemia clusters in some families like any other disease. Predisposition genes should be searched. 2. Cancer prevention and early detection should be continued in CLL patients because of their longevity and high risk for multiple malignancies. 3. The overrepresentation of upper GI malignancies in first degree relatives of CLL patients calls for targeted oesophago-gastroscopy screening studies.

0 Bookmarks
 · 
71 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: A family cancer database was constructed from the nationwide Swedish registries and includes approximately 6 million persons and >30,000 cancers in offspring diagnosed at ages 15-51 years and their parents. A particular advantage of the database is that the contribution of both parental lineages on cancer risk can be examined. Cancer risk in the offspring was increased approximately 1.1 times when the father had cancer, and no increase was noted when the mother had cancer. If both parents had cancer, the risk for sons was 1.4 and for daughters 1.3. The sites of increased cancer risk in the offspring were colorectum, breast, cervix, corpus uteri, ovary, testis, melanoma, eye, other endocrine glands, and multiple myeloma. The results among young and middle-age adults suggest that cancer in both parents increases the cancer risk in the offspring at many sites. The molecular genetic explanation may be that rare dominant single genes increase susceptibility at many sites, or that overlapping sets of genes control susceptibility at multiple sites.
    Genetic Epidemiology 01/1998; 15(3):225-36. · 4.02 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Familial clustering of cancer is well known from epidemiologic studies. This can be due to chance, shared environmental influences, shared genes and chance-environmental-genetic interactions. Family studies are a key to the understanding of the environmental and genetic etiology of chronic disease. Cancer families are human models of susceptibility to neoplasia. More and more people are aware of, and anxious about, their cancer risk. High-risk individuals can benefit from prevention and early detection programs. In medical practice the patient workup should include a carefully obtained family history. This low technology method has the potential for reduction of cancer morbidity and mortality. Every person should create his/her own family tree and discuss it with his/her doctor. This is a step each individual can take for his/her health.
    Anticancer research 01/2001; 21(5):3631-5. · 1.71 Impact Factor
  • American Journal of Preventive Medicine 03/2003; 24(2):128-35. · 3.95 Impact Factor

Full-text (2 Sources)

View
0 Downloads
Available from